Unknown

Dataset Information

0

Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy

ABSTRACT:

SUBMITTER: Yonezawa Ogusuku I 

PROVIDER: S-EPMC10950868 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.
| S-EPMC8928448 | biostudies-literature
Unknown Optimizing engineered TCR T cell therapy for synovial sarcoma
| S-EPMC4645508 | biostudies-literature
Unknown TCR engineered T cells for solid tumor immunotherapy.
| S-EPMC9210724 | biostudies-literature
Unknown Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.
| S-EPMC7427107 | biostudies-literature
Unknown Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.
| S-EPMC10582830 | biostudies-literature
Unknown TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.
| S-EPMC12808264 | biostudies-literature
Unknown Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8α.
| S-EPMC10072215 | biostudies-literature
Unknown CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.
| S-EPMC11980841 | biostudies-literature
Unknown Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors.
| S-EPMC7761868 | biostudies-literature
Unknown TCR-engineered T cell therapy in solid tumors: State of the art and perspectives.
| S-EPMC9931212 | biostudies-literature